annb0t
Top 20
SYDNEY, Dec. 12, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA) received a deficiency notification from the Listing Qualifications Staff of the Nasdaq Stock Market LLC, dated December 9, 2022, notifying the company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Capital Market's rules for continued listing (the "Notice"). Kazia Therapeutics Limited Logo (PRNewsfoto/Kazia Therapeutics Limited)
The deficiency notification has n...
>>> Read more: KAZIA ANNOUNCES RECEIPT OF NASDAQ MINIMUM BID NOTIFICATION
The deficiency notification has n...
>>> Read more: KAZIA ANNOUNCES RECEIPT OF NASDAQ MINIMUM BID NOTIFICATION
